[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-367015-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-367015-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","genome-scale-metabolic-modeling-identifies-synergistic-metabolites-that-enhance-5-fluorouracil-efficacy-in-colon-cancer","Genome-Scale Metabolic Modeling Identifies Synergistic Metabolites that Enhance 5-Fluorouracil Efficacy in Colon Cancer","","Colon cancer remains a major cause of cancer-related death, and 5-fluorouracil (5-FU) efficacy is constrained by resistance and toxicity. This study uses genome-scale metabolic modeling (GEM) to systematically find metabolites that can potentiate 5-FU action in colorectal cancer. The FVSEOF algorithm identifies candidates with altered uptake under TS inhibition. Context-specific metabolic models are built from TCGA data, selecting aspartate, lysine, and valine for validation.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/genome-scale-metabolic-modeling-identifies-synergistic-metabolites-that-enhance-5-fluorouracil-efficacy-in-colon-cancer/367015/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/genome-scale-metabolic-modeling-identifies-synergistic-metabolites-that-enhance-5-fluorouracil-efficacy-in-colon-cancer/367015.png","ImageObject",300,407,{"name":42,"@type":43},"moss~","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-01","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main goal of the study?","Question",{"text":63,"@type":64},"To identify metabolites that synergize with 5-FU to enhance therapeutic efficacy in colorectal cancer using genome-scale metabolic modeling.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which algorithm and data sources were used in the GEM workflow?",{"text":68,"@type":64},"The FVSEOF algorithm was applied to identify metabolites that enhance 5-FU efficacy, while context-specific metabolic models were constructed from TCGA data using the ftINIT algorithm.",{"name":70,"@type":61,"acceptedAnswer":71},"Which metabolites were selected for experimental validation, and why?",{"text":72,"@type":64},"Aspartate, lysine, and valine were predicted as candidates; lysine and valine were selected for experimental validation because they are essential amino acids.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},367015,1790210765,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},962090895452,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Genome-Scale Metabolic Modeling Identifies Synergistic Metabolites that Enhance 5-Fluorouracil Efficacy in Colon Cancer  \nHasan Rahimi-Tamandegani1 , Sayed-Amir Marashi2 , Ghazaleh  \nGhavami 1 , Mahya Mehrmohamadi2* , Soroush Sardari1*  \n1Drug Design and Bioinformatics Unit, Medical Biotechnology Department, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran; 2Department of Biotechnology, College of Science, University of Tehran, Tehran, Iran  \nOPEN ACCESS  \nArticle type: Research Article  \nReceived: July 19, 2025  \nRevised: August 19, 2025  \nAccepted: August 25, 2025  \nPublished online: August 27, 2025  \nHow to cite:  \nRahimi-Tamandegani H, Marashi SA, Ghavami G, Mehrmohamadi M, Sardari S. Genome-Scale Metabolic Modeling Identifies Synergistic Metabolites that Enhance 5-Fluorouracil Efficacy in Colon Cancer. Iran. Biomed. J. 2025; 29(5): 321-334.  \nThis article is licensed under a Creative Commons AttributionNonDerivatives 4.0 International  \nABSTRACT  \nBackground: Colon cancer remains a leading cause of cancer-related mortality, with the efficacy of standard chemotherapy agents such as 5-FU limited by resistance and toxicity. This study aimed to identify metabolites that enhance 5-FU efficacy in CRC using GEM.  \nMethods: GEM was applied using the FVSEOF algorithm to identify metabolites that enhance the therapeutic efficacy of 5-FU in CRC. Contextspecific metabolic models were constructed from TCGA data using the ftINIT algorithm. By simulating TS inhibition, we identified aspartate, lysine, and valine as candidate metabolites with altered uptake under constrained biomass production. Among them, lysine and valine are essential amino acids and were chosen for experimental validation using MTT assays and flow cytometry in HT-29 CRC cells and HU02 normal fibroblasts.  \nResults: Our approach identified aspartate, lysine, and valine as candidate synergistic metabolites. Experimental validation confirmed the strong synergy of lysine and valine with 5-FU in HT-29 cells, while showing significantly reduced effects in normal fibroblasts. Mechanistic analysis suggested that these amino acids enhance nucleotide demand and metabolic activity, amplifying 5-FU-induced stress.  \nConclusion: This study demonstrates synergistic interventions and introduces amino acid co-supplementation as a potential strategy to improve CRC therapy with reduced toxicity. To our knowledge, this is the first study to employ GEM for the systematic prediction of metabolites that synergize with 5-FU, aiming to improve therapeutic outcomes in CRC.  \nLicense. DOI: 10.61882/ibj.5178  \nKeywords: Colorectal neoplasms, Computational biology, Drug synergism, Fluorouracil, Metabolic Networks and Pathways  \nCorresponding Authors:  \nMahya Mehrmohammadi  \nDepartment of Biotechnology, College of Science, University of Tehran, Tehran, Iran; Tel.: (+98-21) 61112720; [E-mail: mehrmohamadi@ut.ac.ir](E-mail: mehrmohamadi@ut.ac.ir); ORCID ID: 0000-0002-6681-0810  \nSoroush Sardari  \nDrug Design and Bioinformatics Unit, Medical Biotechnology Department, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran; Tel.: (+98-21) 66954324; Fax: (+98-21) 66954324; E-mail: [ssardari@hotmail.com](ssardari@hotmail.com); [sardari@pasteur.ac.ir](sardari@pasteur.ac.ir); ORCID ID: 0000-0003-2080-7402  \nINTRODUCTION  \nolon cancer poses a significant global health  \nCburdenapproxi,withmatelyove90r40.900milliodeatnhsnewesticasematesdanidn  \n2022, making it the third most common cancer and the second leading cause of cancer-related mortality[1] . In the United States, there were an estimated 153,020 new CRC cases and 52,550 deaths in 2023. Projections for 2025 indicate a slight increase, with approximately 154,270 new cases and 52,900 deaths expected. These statistics underscore the persistent burden of CRC despite advances in screening and treatment[2,3] . Incidence rates vary widely, with higher rates in developed regions like Europe and Northern America, reflecti","cbCaiuv4UzJShSkW","https://ap.wps.com/l/cbCaiuv4UzJShSkW","pdf",2154274,14,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction","[{\"question\":\"What is the main goal of the study?\",\"answer\":\"To identify metabolites that synergize with 5-FU to enhance therapeutic efficacy in colorectal cancer using genome-scale metabolic modeling.\"},{\"question\":\"Which algorithm and data sources were used in the GEM workflow?\",\"answer\":\"The FVSEOF algorithm was applied to identify metabolites that enhance 5-FU efficacy, while context-specific metabolic models were constructed from TCGA data using the ftINIT algorithm.\"},{\"question\":\"Which metabolites were selected for experimental validation, and why?\",\"answer\":\"Aspartate, lysine, and valine were predicted as candidates; lysine and valine were selected for experimental validation because they are essential amino acids.\"}]","Genome-Scale Metabolic Modeling Identifies Synergistic Metabolites that Enhance 5-Fluorouracil Efficacy in Colon Cancer | PDF",1790168829,35,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/47d7aaaf6481abe5432c14e894a0b8d5.webp",983,1390,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a8b7c904a6e17d2daf25dcb60bcfb115.webp",982,1388,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0fade2a0c830d87927a680765483b4a9.webp",981,1387,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8ff1e36ad838de96b8ebe4dd13cb55a6.webp",980,1385]